BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3982746)

  • 1. Postconception menses induction using prostaglandin vaginal suppositories.
    Foster HW; Smith M; McGruder CE; Richard F; McIntyre J
    Obstet Gynecol; 1985 May; 65(5):682-5. PubMed ID: 3982746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postconceptional fertility control by prostaglandins.
    Toppozada M; Béguin F; Bygdeman M; Wide L; Wiqvist N
    Adv Biosci; 1973; 9():567-73. PubMed ID: 4805870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of silastic vaginal device containing (15S)-15 methyl prostaglandin F2 alpha methyl ester for early first trimester pregnancy termination.
    Robins J
    Prostaglandins; 1976; 12 Suppl():123-34. PubMed ID: 968061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual regulation with prostaglandin (Pg ONO 802) in Indonesia.
    Agoestina T; Sastrawinata S; Prayitno W; Gonta P
    Int J Gynaecol Obstet; 1984 Oct; 22(5):403-9. PubMed ID: 6151928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of prostaglandins and their analogues for abortion.
    Bygdeman M
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS; Stiber AJ; Turkel J
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
    Smith SK; Baird DT
    Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual induction--termination of early pregnancy with a new prostaglandin analogue SHB 286.
    Karim SM; Rao B; Ratnam SS; Prasad RN; Wong YM
    IRCS J Med Sci; 1977 Jan; 5(1):25. PubMed ID: 12338653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 vaginal suppository as an early second trimester abortifacient.
    Bolognese RJ; Corson SL
    Obstet Gynecol; 1974 Jan; 43(1):104-8. PubMed ID: 4808950
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical observations with a prostaglandin-containing silastic vaginal device for pregnancy termination.
    Hendricks CH; Dingfelder JR; Gruber WS
    Prostaglandins; 1976; 12 Suppl():99-122. PubMed ID: 968068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP; Brenner PF; Roy S; Mishell DR
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T; Tabuchi T; Tabei T; Kaku R
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The induction of abortion and menstruation by the intravaginal administration of prostaglandin F 2a .
    Sato T; Ami K; Matsumoto S
    Am J Obstet Gynecol; 1973 May; 116(2):287-9. PubMed ID: 4704006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First experiences with a (15S)-15-methyl prostaglandin F2alpha vaginal device for termination of early first trimester pregnancy with serial sonographic observations.
    Duenhoelter JH; Santos-Ramos R
    Prostaglandins; 1976; 12 Suppl():135-45. PubMed ID: 968062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pregnancy interruption with a single PGF2 alpha 15-methyl-analogue vaginal suppository.
    Borten M; Friedman EA
    J Reprod Med; 1985 Oct; 30(10):741-4. PubMed ID: 3877806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.